Abstract:Abstract Cell-free DNA (cfDNA) and DNA binding proteins are released in the circulation upon systemic inflammation, the extent of which is proportional to the severity of the systemic inflammation. There is an ongoing debate on the cellular source of cfDNA during systemic inflammatory conditions. During infection, circulating histones and DNA in the form of nucleosomes have been argued to be released by activated neutrophils in the process of NETosis. However, cfDNA has also been attributed to the cell death of other cell types, such as lymphocytes and endothelial cells. The objective of the current study is to investigate the compartmental source of extracellular DNA released into the circulation during a systemic inflammatory response. We determined the plasma levels of nucleosomes as a measure of cfDNA and DNA binding proteins, and of elastase-α1-antitrypsin (EA) complexes as a measure of neutrophil activation in different systemic inflammatory responses. First, we induced a low-grade endotoxemia in eight healthy human subjects by injection of lipopolysaccharide (LPS). In these subjects, nucleosome levels increased to a maximum at 3 hours after LPS injection (mean 529 ± SE 112 AU/ml), after which they returned towards baseline levels. Interestingly, the release of EA showed similar kinetics as that of nucleosomes, reaching a maximal level of 499 ± 58 ng/ml at 3 hours. Furthermore, plasma EA levels positively correlated with nucleosome levels during LPS challenge (r=0,79; p<0.0001), suggesting that during a mild, transient inflammatory response, neutrophils are the predominant source of nucleosomes within the plasma. We next measured nucleosomes and neutrophil activation in twenty patients with severe systemic inflammation caused by sepsis. Surprisingly, sequential measurements in sepsis patients did not show a correlation between plasma EA levels and nucleosome levels (r=0,155; p=0,13), suggestive of a non-neutrophil source of cfDNA. Thus, there might be other potential cellular sources of cfDNA than neutrophils in a severe systemic inflammation. To further investigate the difference of cfDNA release between a mild and a severe systemic inflammation, we used chimeric mice transplanted with bone marrow of the opposite sex. After hematopoietic recovery, mice were challenged with LPS. We were able to follow up on the release of cfDNA from different compartmental sources, that is either the hematopoietic or the non-hematopoietic compartment, by using a specific mouse SRY qPCR as a measure for male DNA, and IL3 qPCR as a measure for total DNA. CfDNA from the hematopoietic compartment was present within the plasma of the mice at 6 and 20 hours after LPS challenge, whereas cfDNA from a parenchymal source could be detected at 20 hours but less at 6 hours after LPS challenge. This suggests that the hematopoietic compartment acts as a source of cfDNA both early and late after LPS challenge, whereas the parenchymal compartment only releases DNA at later stages of severe systemic inflammation. Collectively, our results show that in severe systemic inflammation, circulating cfDNA originates from both hematopoietic cells (e.g. neutrophils and lymphocytes) and parenchymal cells (e.g. endothelial cells). Understanding the kinetics of extracellular DNA may improve knowledge on duration and severity of sepsis and may provide a point of interference during systemic inflammation. Disclosures No relevant conflicts of interest to declare.

Elucidating the biological effects of cell-free DNA (cfDNA) extracted from septic mice: In Vitro and In Vivo investigations and mechanistic insights

Recent advances in the biology of IL-1 family cytokines and their potential roles in development of sepsis.

Role of cell-free DNA levels in the diagnosis and prognosis of sepsis and bacteremia: A systematic review and meta-analysis

Compact bone mesenchymal stem cells-derived paracrine mediators for cell-free therapy in sepsis

Inhibiting DNA Methylation Improves Survival in Severe Sepsis by Regulating NF-κB Pathway.

Diagnostic Potential of Plasma Extracellular Vesicle Mir-483-3p and Let-7d-3p for Sepsis.

THE EFFECTS OF DNASE I AND LOW-MOLECULAR-WEIGHT HEPARIN IN A MURINE MODEL OF POLYMICROBIAL ABDOMINAL SEPSIS

Cell-free DNA in patients with sepsis: long term trajectory and association with 28-day mortality and sepsis-associated acute kidney injury

Nanomechanical detection to empower robust monitoring of sepsis and microbial adaptive immune system-mediated proinflammatory disease

Extracellular DNA and Deoxyribonuclease Activity as Prognostic Markers in Sepsis

Cell-Free Nuclear and Mitochondrial DNA as Potential Biomarkers for Assessing Sepsis Severity

Systemic Inflammation Induces Release of Cell-Free DNA from Hematopoietic and Parenchymal Cells in Mice and Human

Single-cell RNA sequencing reveals cell–cell communication and potential biomarker in sepsis and septic shock patients

MicroRNA as Sepsis Biomarkers: A Comprehensive Review

Cell-free DNA: a promising biomarker in infectious diseases

Identification of key biomarkers and therapeutic targets in sepsis through coagulation-related gene expression and immune pathway analysis

Exosomes Derived from Septic Mouse Serum Modulate Immune Responses Via Exosome-Associated Cytokines.

Elucidating common pathogenic transcriptional networks in infective endocarditis and sepsis: integrated insights from biomarker discovery and single-cell RNA sequencing

Cell-free chromatin particles released from dying host cells are global instigators of endotoxin sepsis in mice

A Cationic Metal–Organic Framework to Scavenge Cell-Free DNA for Severe Sepsis Management

Mechanistic insights into cell-free hemoglobin-induced injury during septic shock